Market Value2,360,081,000
Total Holdings64
File Date2014-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
XLRN / Acceleron Pharma Inc
ARAY / Accuray Incorporated
AKRX / Akorn, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
ALGN / Align Technology, Inc.
018490100 / Allergan plc
ANTH / Anthera Pharmaceuticals, Inc.
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
PTCT / PTC Therapeutics, Inc.
OMED / OptMed Inc
SHPG / Shire Plc.
HTWR / Heartware International Inc.
CELG / Celgene Corp.
CMRX / Chimerix, Inc.
CLVS / Clovis Oncology Inc
AMGN / Amgen Inc.
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
HALO / Halozyme Therapeutics, Inc.
ISRG / Intuitive Surgical, Inc.
IMGN / ImmunoGen, Inc.
INGN / Inogen, Inc.
ICPT / Intercept Pharmaceuticals Inc
IRWD / Ironwood Pharmaceuticals, Inc.
DXCM / DexCom, Inc.
KPTI / Karyopharm Therapeutics Inc.
KERX / Keryx Biopharmaceuticals, Inc.
TMO / Thermo Fisher Scientific Inc.
US00C4U1L353 / Mylan N.V.
MDVN / Medivation, Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
GILD / Gilead Sciences, Inc.
NPSP / NPS Pharmaceuticals Inc
NVS / Novartis AG - Depositary Receipt (Common Stock)
0PP / Portola Pharmaceuticals Inc
NXTM / NxStage Medical, Inc.
RLYP / Relypsa, Inc.
CI / The Cigna Group
GEVA / Synageva Biopharma Corp
SGNT / Sagent Pharmaceuticals, Inc.
TNDM / Tandem Diabetes Care, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
INVA / Innoviva, Inc.
91911K102 / Bausch Health Companies
WX / Wuxi Pharmatech (Cayman) Inc.
VRTX / Vertex Pharmaceuticals Incorporated
ILMN / Illumina, Inc.
G0083B108 / Actavis
COV /
MNKKQ / Mallinckrodt Plc
TBPH / Theravance Biopharma, Inc.
PRGO / Perrigo Company plc
INCY / Incyte Corporation
RNA / Avidity Biosciences, Inc.
WMGIZ / Wright Medical Group N.V.
BMRN / BioMarin Pharmaceutical Inc.
UTHR / United Therapeutics Corporation
SGEN / Seagen Inc
REGN / Regeneron Pharmaceuticals, Inc.
MRK / Merck & Co., Inc.
ABBV / AbbVie Inc.
INSM / Insmed Incorporated
BIIB / Biogen Inc.
BSX / Boston Scientific Corporation